Literature DB >> 17393106

Effects of shRNA targeting VEGF on VEGF mRNA expression in gastric cancer cells.

Yahua Hu1, Xiaohua Hou, Dongqing Li, Weijin Chen, Hongliang Wang, Xiaolian Zhang.   

Abstract

In order to investigate the inhibitory effect of plasmid-mediated short hairpin RNA targeting vascular endothelial growth factor (VEGF) on the expression of VEGF mRNA in human gastric cancer cells, a plasmid vector for transcribing specific short hairpin RNA targeting VEGF (pU6-VEGF) was constructed, and then transfected into human gastric cancer cells using Lipofectamine2000. The VEGF mRNA expression level was detected by RT-PCR. RPMI1640 was used for blank control, and pSilencer 1.0-U6 empty plasmid for the negative control. Results showed the clone and sequence analysis revealed that the recombinant plasmid vector of pU6-VEGF was successfully constructed. The VEGF mRNA expression levels in blank control group, experimental group (pU6-VEGF) and negative control group (pSilencer1.0-U6) were 100%, 49% and 94%, respectively, indicating VEGF mRNA expression in the cells transfected with pU-VEGF vector was inhibited significantly as compared with blank control group and negative control group. It was concluded that the short hairpin RNA could significantly inhibit the expression of VEGF mRNA, which provided an experimental basis for treating human cancer with anti-angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393106     DOI: 10.1007/s11596-007-0112-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Counting the dead and what they died from: an assessment of the global status of cause of death data.

Authors:  Colin D Mathers; Doris Ma Fat; Mie Inoue; Chalapati Rao; Alan D Lopez
Journal:  Bull World Health Organ       Date:  2005-03-16       Impact factor: 9.408

Review 4.  Angiogenesis inhibitors in the treatment of cancer.

Authors:  Jay Rhee; Paulo M Hoff
Journal:  Expert Opin Pharmacother       Date:  2005-08       Impact factor: 3.889

5.  Overexpression of vascular endothelial growth factor is responsible for the hematogenous recurrence of early-stage gastric carcinoma.

Authors:  H Konno; M Baba; T Tanaka; K Kamiya; M Ota; K Oba; A Shoji; T Kaneko; S Nakamura
Journal:  Eur Surg Res       Date:  2000       Impact factor: 1.745

6.  Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo.

Authors:  Francesca Wannenes; Silvia Anna Ciafré; Francesco Niola; Gaetano Frajese; Maria Giulia Farace
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

7.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

Review 8.  RNA interference and human disease.

Authors:  Jerry C Cheng; Theodore B Moore; Kathleen M Sakamoto
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

9.  Expression of VEGF and brain specific angiogenesis inhibitor-1 in glioblastoma: prognostic significance.

Authors:  Do-Hyun Nam; Kwan Park; Yeon Lim Suh; Jong-Hyun Kim
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.